Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

139

Figures (1-1)

Tables (1-4)

Sum=215

Publishing Process of This Article

Item

Count

Browse

Download

Sum=5

Jun 27, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastrointest Surg. Jun 27, 2024; 16(6): 1756-1764
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1756

Table 4 Comparison of complication rates between the two groups, n (%)

Index	TACE + RFA group (n = 45)	RFA group (n = 45)	χ²	P value
Fever	3	2
Bleeding	1	1
Liver abscess	1	0
Nausea and vomiting	1	1
Upper gastrointestinal bleeding	1	0
Abdominal pain	1	1
Abnormal liver function	4	3
Total incidence rate	12 (26.67)	8 (17.78)	2.286	0.131

TACE: Transcatheter arterial chemoembolization; RFA: Radiofrequency ablation.

Citation: Guo JY, Zhao LL, Cai HJ, Zeng H, Mei WD. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer. World J Gastrointest Surg 2024; 16(6): 1756-1764
URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1756.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1756